PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC
Clinical trial NCT07645222 · RECRUITING
Trial details
- NCT number
- NCT07645222
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2028-10-31
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.